Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Mayo Clinic
German CLL Study Group
Karolinska University Hospital
Columbia University
Garcia, Jose M., MD, PhD
University Health Network, Toronto
National Cancer Institute (NCI)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
European Organisation for Research and Treatment of Cancer - EORTC